HDFC Pharma and Healthcare Fund vs Nippon India ETF Nifty 50 Shariah BeES
Portfolio Overlap Analysis · HDFC vs Nippon
10.9%
Low Overlap
2 common stocks · Rank #19216 of 28,292 pairs
Common Holdings (2)
| Stock | Wt% in HDFC Pharma and Healthcare | Wt% in Nippon India ETF Nifty 50 Shar | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology | 7.59% | 9.81% | 7.59% |
Max Healthcare Institute Limited Healthcare Services | 3.35% | 6.36% | 3.35% |
Unique to HDFC Pharma and Healthcare
- Divis Laboratories Ltd.8.38%
- Glenmark Pharmaceuticals Ltd.6.62%
- Lupin Ltd.6.44%
- Alkem Laboratories Ltd.6.21%
- Aster DM Healthcare Limited5.42%
- Ipca Laboratories Ltd.4.80%
- Anthem Biosciences Limited4.46%
- Fortis Healthcare Limited4.02%
Unique to Nippon India ETF Nifty 50 Shar
- Infosys Limited18.80%
- Tata Consultancy Services Limited11.12%
- Hindustan Unilever Limited8.57%
- UltraTech Cement Limited6.20%
- HCL Technologies Limited6.05%
- Hindalco Industries Limited5.52%
- Oil & Natural Gas Corporation Limited4.48%
- Asian Paints Limited4.44%
- Nestle India Limited3.82%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology7.6% (1)
Healthcare Services3.4% (1)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFC Pharma and Healthcare
- vs SBI Healthcare Opportunities54.8% · 16 stocks
- vs HEALETF46.5% · 10 stocks
- vs NH42.6% · 10 stocks
- vs NIPPON INDIA PHARMA41.7% · 13 stocks
- vs ICICI Prudential Nifty Pharma 40.0% · 9 stocks
More comparisons for Nippon India ETF Nifty 50 Shar
- vs HDFCG15ETF43.3% · 5 stocks
- vs SBI Equity Minimum Variance41.6% · 17 stocks
- vs ICICI Prudential Nifty50 Value40.0% · 8 stocks
- vs NV20ETF40.0% · 8 stocks
- vs NZ39.5% · 4 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.